Omkar Pharmachem Ltd vs Swarna Securities Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Omkar Pharmachem Ltd is ₹ 29.5 as of 16 Feb 15:30 . The P/E Ratio of Omkar Pharmachem Ltd changed from 113.3 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Swarna Securities Ltd changed from 6.3 on March 2021 to 21.6 on March 2025 . This represents a CAGR of 27.94% over 5 years The Market Cap of Omkar Pharmachem Ltd changed from ₹ 20.57 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Swarna Securities Ltd changed from ₹ 3.84 crore on March 2021 to ₹ 17.48 crore on March 2025 . This represents a CAGR of 35.41% over 5 years The revenue of Omkar Pharmachem Ltd for the Dec '25 is ₹ 0.11 crore as compare to the Sep '25 revenue of ₹ 0.14 crore. This represent the decline of -21.43% The revenue of Swarna Securities Ltd for the Dec '25 is ₹ 0.35 crore as compare to the Sep '25 revenue of ₹ 0.39 crore. This represent the decline of -10.26% The ebitda of Omkar Pharmachem Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.07 crore. This represent the decline of -42.86% The ebitda of Swarna Securities Ltd for the Dec '25 is ₹ 0.31 crore as compare to the Sep '25 ebitda of ₹ 0.32 crore. This represent the decline of -3.12% The net profit of Omkar Pharmachem Ltd changed from ₹ 0.05 crore to ₹ 0.03 crore over 7 quarters. This represents a CAGR of -25.32% The net profit of Swarna Securities Ltd changed from ₹ 0.14 crore to ₹ 0.25 crore over 7 quarters. This represents a CAGR of 39.28% The Dividend Payout of Omkar Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Swarna Securities Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated on 31 March 1995.
The Company has not done any commercial activity during the year.
At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product in 2017-18. The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
Currently, Company is engaged in business of providing support services related activities.

About Swarna Securities Ltd

Swarna Securities Limited was incorporated in 1990.
The Company provides hire purchase and hypothecation loans and advances in India.
It trades in shares.
With the surrender of the NBFC Certificate of Registration to the Reserve Bank of India, the Company has stopped the business of Non-Banking Finance Company.
There has been no fresh issue of any loans during the year.

FAQs for the comparison of Omkar Pharmachem Ltd and Swarna Securities Ltd

Which company has a larger market capitalization, Omkar Pharmachem Ltd or Swarna Securities Ltd?

Market cap of Omkar Pharmachem Ltd is 29 Cr while Market cap of Swarna Securities Ltd is 27 Cr

What are the key factors driving the stock performance of Omkar Pharmachem Ltd and Swarna Securities Ltd?

The stock performance of Omkar Pharmachem Ltd and Swarna Securities Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Omkar Pharmachem Ltd and Swarna Securities Ltd?

As of March 23, 2026, the Omkar Pharmachem Ltd stock price is INR ₹29.5. On the other hand, Swarna Securities Ltd stock price is INR ₹89.99.

How do dividend payouts of Omkar Pharmachem Ltd and Swarna Securities Ltd compare?

To compare the dividend payouts of Omkar Pharmachem Ltd and Swarna Securities Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.